Newer Not Necessarily Better. An October 2006 issue of Archives of General Psychiatry has published a report that suggests second-generation ("newer") antipsychotic medications offered little advantage over older drugs for schizophrenic patients, which runs counter to a wide belief that newer antipsychotic agents are safer and more effective. Based on ...
Welcome to the October 3, 2006 edition of Carnival of Depression, Bipolar Disorder, and Mental Health Journeys.
depression
Steve Woodruff presents Clearing Clouds posted at Steve Woodruff, saying, "At first, it was like walking out on a frozen pond. You gingerly put a foot forward, and silently ask, “Will it hold me?” ...
Corcept Therapeutics' lead drug, Corlux is being studied for its ability to reduce the psychotic symptoms of major depression in patients. Corlux is a Glucocorticoid receptor type II (GRII) antagonist and may be better "known" as the controversial mifepristone (or RU-486, otherwise known as the "morning after" pill). The company ...